Editor's PickMarket News

NA Proactive news snapshot: Q BioMed, Lithoquest Diamonds, KushCo Holdings, Matinas BioPharma, Lucky Minerals, Todos Medical …

Q BioMed Inc (OTCQB:QBIO) on Friday announced that its marketing campaign for Strontium89, a US Food and Drug Administration-approved treatment for the pain associated with bone cancer, has been selected for inclusion in the Ads of the World, a curated archive of the world’s best creative campaigns. The company noted that this recognition supports its efforts in making Strontium89 available to patients who need relief from metastatic bone cancer pain. Lithoquest Diamonds Inc (CVE:LDI) Friday announced that the company’s Board of Directors have approved a corporate name change to “Lithoquest Resources Inc”. The company now known as Lithoquest Resources will begin trading on the Toronto Venture exchange on Tuesday, November 24, 2020 under the same stock symbol: LDI.   KushCo Holdings Inc (OTCQX:KSHB) said Friday that it has teamed up with United Pacific, one of the largest owners of gas stations and convenience stores in the western United States, to expand CBD distribution across 350 locations in California, Nevada, Oregon, Washington and Colorado. Since 1955, United Pacific has been offering motor fuels products under the 76, Conoco, Shell and United Oil brands, and convenience items through the We Got It! Food Mart, My Goods Market, and Circle K brands. Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) (FRA:6LJ) has unveiled positive news for its oral Amikacin (MAT2501) candidate, with the firm awarded $3.75 million from the Cystic Fibrosis Foundation (CFF) to support the drug’s pre-clinical development as a treatment for nontuberculous mycobacterial (NTM) lung disease, including infections in cystic fibrosis (CF) sufferers. The funds will allow the biotech group to rapidly advance the development of MAT2501 and support preclinical in-vitro and in-vivo studies, along with several toxicology studies necessary to progress the drug into Phase 2 trials. Notably, the CFF has also indicated it may be willing to fund the continuation of clinical studies, including dose determination and Phase 2 efficacy studies in CF patients suffering from NTM lung disease. Lucky Minerals Inc (CVE:LKY) (OTCMKTS:LKMNF) (FRA:LKY1) has reported positive exploration results from the Sherman prospect, part of the firm’s Fortuna 4 gold and copper project in Ecuador. In a statement, the company said it has now identified an area, comprised of three zones, which has potential to be a bulk tonnage, low-grade gold target. This area is characterized by quartz veins hosted in schists, showing up to 1.66 grams per ton (g/t) gold, Lucky said. Todos Medical Ltd (OTCQB:TOMDF) has announced positive in vitro data for its dietary supplement Tollovid that shows its ability to inhibit the 3CL protease, an enzyme that facilitates intracellular replication of coronaviruses. Tollovid is an orally administered proprietary blend of plant extracts that includes a powerful 3CL protease inhibitor that helps support and maintain healthy immune function. Todos and its joint venture partner NLC Pharma said that researchers believe the 3CL protease plays a significant role in coronavirus replication, allowing the processing of proteins encoding viral RNA. Inhibiting this activity could stop the ability of the virus to replicate and prevent its spread throughout the body. Codebase Ventures Inc (CSE:CODE) (FRA:C5B) (OTCQB:BKLLF), a tech-centric investment company, revealed Friday that its portfolio holding Arcology Network, which is a blockchain company, has successfully conducted its first testnet and achieved internal targets. Arcology, in which Codebase owns a 30% stake, is a radically new hierarchical blockchain that uses proprietary algorithms and artificial intelligence to eliminate inefficiencies that hinder rival blockchain platforms. Codebase said the testnet represents the “key step” to verifying that Arcology’s design works as expected under a high workload. As Bitcoin and Ethereum prices increase, Arcology has demonstrated compatibility with Ethereum. IEC Electronics Corp (NASDAQ:IEC) reported Friday that it produced $46.4 million in revenue during its fiscal 2020 fourth quarter — a nearly 6% year-over-year increase. Higher sales in the quarter ended September 30, helped the company achieve net income of $1.9 million, or $0.18 per basic and diluted share. That compares to net income of $1.8 million, or $0.17 per basic and diluted share, in the year-ago quarter. The New York company also announced full-year, fiscal 2020 results highlighting its healthy growth over the last 12 months.  Biocept Inc (NASDAQ:BIOC) (FRA:B003), a provider of molecular diagnostic assays, announced Friday that its Target Selector CSF assays are a viable and sensitive platform for circulating tumor cell (CTC) detection, according to a study analyzing cerebrospinal fluid (CSF) samples in patients with primary lung or breast cancer with either brain or leptomeningeal disease. The findings indicate that Target Selector assays compared favorably to the current standard of care, CSF cytology, which is used to confirm leptomeningeal disease when imaging findings are not sufficient. CSF cytology has limited sensitivity and provides no additional information needed for target therapy choice, the company said. ImagineAR Inc (CSE:IP) (OTCQB:IPNFF) (FRA:GMS1) announced Friday it will work with Shoppers Drug Mart and the event production agency HUMANCONTACT Inc to deliver an immersive augmented reality experience to over 2,500 corporate staff, pharmacist-owners, and front store managers across Canada. Using the ImagineAR Custom White-label mobile app, Shoppers Drug Mart will integrate dynamic AR into the live-streamed virtual event sessions. Shoppers Drug Mart is the country’s largest pharmacy chain. Media Central Corporation Inc (CSE:FLYY) (FRA:3AT) late Thursday announced the appointment of three new directors to the company’s board, and also said its chief financial officer (CFO) has been reinstated. The company’s three new board members are: David Daniels, currently President and CEO of commercial and industrial lighting company Etlin Daniels, who is serial business entrepreneur with a successful 35-year track record of profitable small business ownership; Emmanuel Manos Pavlakis is a successful entrepreneur with 30 years’ experience in building companies in markets including manufacturing, commercial and industrial real estate and investment banking, with companies such as Noble Precision Tooling Inc., Megafoam Inc. and Powergundrilling Inc.; and Jay Vieira, a corporate and securities lawyer, who was formerly a partner at Blaney McMurtry LLP and Fogler Rubinoff LLP. The group also said that Rodney Davis has been reinstated as the company’s CFO, effective immediately, following Igor Kostioutchenko’s resignation as interim CFO. Melkior Resources Inc (CVE:MKR) (OTCMKTS:MKRIF) (FRA:MEK1) has boosted its White Lake project in Ontario, by striking a milestone deal with mining titan Barrick Gold Corp (NYSE:GOLD) (TSE:ABX) (FRA:ABR), giving the latter the right to earn up to 75% of the property. The project lies 20km east of Barrick’s producing Hemlo mine, where the major wants to extend the mine-life.  BevCanna Enterprises Inc. (CSE:BEV) (OTCQB:BVNNF) (FRA:7BC), a developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients, has said it will host a special management call to discuss upcoming corporate milestones and review recent developments on Tuesday, November 24, 2020, at 1.30pm PT. The teleconference will be hosted by BevCanna CEO Marcello Leone and CFO John Campbell, and Executive Management Advisor Keith Dolo. BevCanna also announced the debut of its broadcast feature on BNN Bloomberg on Monday November 23, 2020, where CEO Leone will be interviewed on the company’s strategy, upcoming launch in the Canadian cannabis market and progress on its international initiatives. To join the teleconference, investors can use the following dial-in information: US/Canada (toll-free): 1-800-319-4610; UK (toll-free): 0808-101-2791. A replay of the call will be available for seven days following the conclusion of the live call. In order to access the replay, dial 1-800-319-6413 (toll-free) and use the passcode 5703#. The company will also provide a recap of the management teleconference and provide links to the Bloomberg BNN interview. Webcast Participants link: http://services.choruscall.ca/links/bevcanna20201124.html American Manganese Inc. (CVE:AMY) (OTCPINK:AMYZF) (FRA:2AM) has said it will be extending the exercise period for 10,158,225 share purchase warrants, all of which are exercisable at $0.20 per share. The warrants were issued pursuant to two private placement which closed over several tranches in 2018 and 2019. The company proposes to extend the expiry dates for all Warrants by one year, and accordingly, the new expiry dates for the Warrants are as follows: Tranche 1: For Warrants issued on December 4, 2018, the new expiration date will be December 4, 2021; Tranche 2: For Warrants issued on January 11, 2019, the new expiration date will be January 11, 2022; Tranche 3: For Warrants issued on March 29, 2019, the new expiration date will be March 29, 2022; Tranche 4: For Warrants issued on May 3, 2019, the new expiration date will be May 3, 2022. For Private Placement of Flow-Through Units warrants issued on December 26, 2018, the new expiration date will be December 26, 2021. All other terms and conditions of the warrants remain unchanged.

Leave a Reply

Your email address will not be published. Required fields are marked *